- Company Details
This Small Business Innovation Research Phase II project develops positron emission tomography (PET) imaging products to manage neurodegenerative disorders, cancer, and cardiovascular disease. PET is ...SBIRPhase II2014National Science Foundation
This Small Business Innovation Research Phase I project will support a new synthetic chemical approach for the creation of positron emission tomography (PET) imaging products to manage neurodegenerati ...SBIRPhase I2012National Science Foundation
Ground Fluor Pharmaceuticals, Inc.
Lincoln, NE, 68503-2495
|# of Employees:||1|
|Socially and Economically Disadvantaged:||N|